CGEM
USDCullinan Therapeutics Inc. Common Stock
$7.400-0.400 (-5.128%)
Prix en Temps Réel
Healthcare
Biotechnologie
États-Unis
Graphique des Prix
Loading Chart...
Métriques Clés
Métriques de Marché
Ouverture
$7.800
Haut
$7.800
Bas
$7.360
Volume
0.61M
Fondamentaux de l'Entreprise
Capitalisation Boursière
437.2M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.89M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Bas $5.68Actuel $7.400Haut $17.503
Actualités Connexes
GlobeNewswire
Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeting
CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, regardless of FLT3 mutational status ~30% CRc rate observed at clinically
Voir plus
GlobeNewswire
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
CLN-978 led to rapid and deep B cell depletion in vitro and in vivo in multiple autoimmune diseases CAMBRIDGE, Mass., Oct. 25, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (NASDAQ:CGEM), a clinical-stage
Voir plus
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.